Page last updated: 2024-08-07 16:46:24
Presenilin-2
A presenilin-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P49810]
Synonyms
PS-2;
EC 3.4.23.-;
AD3LP;
AD5;
E5-1;
STM-2
Research
Bioassay Publications (29)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (20.69) | 29.6817 |
2010's | 20 (68.97) | 24.3611 |
2020's | 3 (10.34) | 2.80 |
Compounds (21)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
cholanic acid | Homo sapiens (human) | EC50 | 5.7000 | 1 | 1 |
t0901317 | Homo sapiens (human) | EC50 | 3.6000 | 1 | 1 |
ly 450139 | Homo sapiens (human) | EC50 | 0.1259 | 1 | 1 |
ly 411575 | Homo sapiens (human) | EC50 | 0.0001 | 1 | 1 |
begacestat | Homo sapiens (human) | EC50 | 0.0136 | 2 | 2 |
e 2012 | Homo sapiens (human) | EC50 | 0.0830 | 1 | 1 |
ro 4929097 | Homo sapiens (human) | EC50 | 0.0095 | 2 | 2 |
Drugs with Other Measurements
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 25, Issue:4, 2015
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Novel Notch-sparing gamma-secretase inhibitors derived from a peroxisome proliferator-activated receptor agonist library.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 20, Issue:17, 2010
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Development of clickable active site-directed photoaffinity probes for γ-secretase.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 22, Issue:8, 2012
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Small molecules targeting γ-secretase and their potential biological applications.European journal of medicinal chemistry, , Mar-15, Volume: 232, 2022
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Piperidine-derived gamma-secretase modulators.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 20, Issue:3, 2010
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations.The Journal of biological chemistry, , Aug-24, Volume: 282, Issue:34, 2007
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
N-Substituted carbazolyloxyacetic acids modulate Alzheimer associated gamma-secretase.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 17, Issue:1, 2007
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Small molecules targeting γ-secretase and their potential biological applications.European journal of medicinal chemistry, , Mar-15, Volume: 232, 2022
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 23, Issue:4, 2013
Effect of helical conformation and side chain structure on γ-secretase inhibition by β-peptide foldamers: insight into substrate recognition.Journal of medicinal chemistry, , Feb-28, Volume: 56, Issue:4, 2013
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Generation of Leads for γ-Secretase Modulation.Journal of medicinal chemistry, , 08-13, Volume: 63, Issue:15, 2020
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.European journal of medicinal chemistry, , Mar-25, Volume: 148, 2018
Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.ACS medicinal chemistry letters, , Oct-12, Volume: 8, Issue:10, 2017
Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?Journal of medicinal chemistry, , Aug-25, Volume: 59, Issue:16, 2016
Potent benzoazepinone γ-secretase modulators with improved bioavailability.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 25, Issue:17, 2015
Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators.Journal of medicinal chemistry, , Nov-08, Volume: 55, Issue:21, 2012
Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo.Journal of medicinal chemistry, , Jan-12, Volume: 55, Issue:1, 2012
Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 21, Issue:2, 2011
Iminoheterocycles as gamma-secretase modulators.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 20, Issue:18, 2010
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors.Journal of medicinal chemistry, , Nov-25, Volume: 58, Issue:22, 2015
4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 16, Issue:2, 2006
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.European journal of medicinal chemistry, , Mar-25, Volume: 148, 2018
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014.Bioorganic & medicinal chemistry letters, , May-01, Volume: 21, Issue:9, 2011
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.European journal of medicinal chemistry, , Mar-25, Volume: 148, 2018
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 23, Issue:4, 2013
Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active γ-secretase inhibitor.Journal of medicinal chemistry, , Apr-12, Volume: 55, Issue:7, 2012
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 23, Issue:4, 2013
Enables
This protein enables 2 target(s):
Target | Category | Definition |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
aspartic endopeptidase activity, intramembrane cleaving | molecular function | Catalysis of the hydrolysis of nonterminal peptide bonds in a polypeptide chain, occurring within a membrane. [GOC:jl, ISBN:0198506732] |
Located In
This protein is located in 12 target(s):
Target | Category | Definition |
Golgi membrane | cellular component | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. [GOC:mah] |
kinetochore | cellular component | A multisubunit complex that is located at the centromeric region of DNA and provides an attachment point for the spindle microtubules. [GOC:elh] |
nuclear inner membrane | cellular component | The inner, i.e. lumen-facing, lipid bilayer of the nuclear envelope. [GOC:ma] |
early endosome | cellular component | A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways. [GOC:mah, NIF_Subcellular:nlx_subcell_20090701, PMID:19696797] |
endoplasmic reticulum | cellular component | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). [ISBN:0198506732] |
endoplasmic reticulum membrane | cellular component | The lipid bilayer surrounding the endoplasmic reticulum. [GOC:mah] |
Golgi apparatus | cellular component | A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways. [ISBN:0198506732] |
centrosome | cellular component | A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle. [GOC:mah, ISBN:0198547684] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
synaptic vesicle | cellular component | A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane. [PMID:10099709, PMID:12563290] |
membrane | cellular component | A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it. [GOC:dos, GOC:mah, ISBN:0815316194] |
presynaptic membrane | cellular component | A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane. [GOC:jl, ISBN:0815316194] |
Part Of
This protein is part of 2 target(s):
Target | Category | Definition |
protein-containing complex | cellular component | A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together. [GOC:dos, GOC:mah] |
gamma-secretase complex | cellular component | A protein complex that has aspartic-type endopeptidase activity and contains a presenilin catalytic subunit (either PSEN1 or PSEN2), an APH1 subunit (multiple genes and splice variants exist), nicastrin (NCT), and presenilin enhancer (aka PEN-2 or Psenen), as the core complex. Variants of the complex with different subunit compositions differ in localization and specific substrates. Additionally, variants of the complex exist that contain a additional regulatory subunit as well as the four core subunits; known regulatory subunits include gamma-secretase-activating protein (aka gSAP), TMP1 (aka TMED10), and CD147 antigen (aka basigin). Gamma-secretase cleaves type I transmembrane protein substrates, including the cell surface receptor Notch and the amyloid-beta precursor protein. [GOC:krc, PMID:15286082, PMID:15890777, PMID:17047368, PMID:22122073, PMID:25565961, PMID:28320827, PMID:32616437] |
Involved In
This protein is involved in 11 target(s):
Target | Category | Definition |
response to hypoxia | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. [GOC:hjd] |
membrane protein ectodomain proteolysis | biological process | The proteolytic cleavage of transmembrane proteins and release of their ectodomain (extracellular domain). [GOC:jl, http://www.copewithcytokines.de/] |
Notch receptor processing | biological process | The series of successive proteolytic cleavages of the Notch protein, which result in an active form of the receptor. [PMID:12651094, PMID:14986688] |
protein processing | biological process | Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein. [GOC:curators, GOC:jl, GOC:jsg] |
amyloid-beta formation | biological process | The generation of amyloid-beta by cleavage of the amyloid precursor protein (APP). [GOC:mah] |
intracellular signal transduction | biological process | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. [GOC:bf, GOC:jl, GOC:signaling, ISBN:3527303782] |
amyloid precursor protein catabolic process | biological process | The chemical reactions and pathways resulting in the breakdown of amyloid precursor protein (APP), the precursor of amyloid-beta, a glycoprotein associated with Alzheimer's disease. [GOC:go_curators] |
regulation of calcium import into the mitochondrion | biological process | Any process that modulates the frequency, rate or extent of calcium import into the mitochondrion. [GOC:sl, PMID:24085037] |
mitochondrion-endoplasmic reticulum membrane tethering | biological process | The attachment of a mitochondrion and an endoplasmic reticulum via molecular tethers that physically bridge their respective membranes and attach them to each other. The tethering may facilitate exchange of metabolites between the organelles. [PMID:19556461, PMID:27875684] |
calcium ion homeostasis | biological process | Any process involved in the maintenance of an internal steady state of calcium ions within an organism or cell. [GOC:ceb, GOC:jid, GOC:mah] |
Notch signaling pathway | biological process | The series of molecular signals initiated by an extracellular ligand binding to the receptor Notch on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. [GOC:go_curators, GOC:signaling] |